Phase I clinical and pharmacokinetic (PK) trial of the kinesin spindle protein (KSP) inhibitor MK-0731 in cancer patients
Year: 2006
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: M. N. Stein, E. H. Rubin, P. D. Scott, R. Fernandez, N. G. Agrawal, K. Hsu, A. Walker, K. Holen, G. Wilding
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2532474449
